Kiniksa Pharmaceuticals International, plc Class A KNSA
NASDAQ · United States · Health Technology
$75.85+1.24 (+1.66%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-28 | 0.30 | 0.30 | +0.2% | $243.60M | +7.6% | +27.4%$63.53→$80.92 |
| Q1 2026 | 2026-04-28 | 0.27 | 0.16 | +68.8% | — | — | +21.5% |
| Q4 2025 | 2026-02-24 | 0.17 | 0.40 | -57.5% | — | — | -9.8%$47.39→$42.76 |
| Q3 2025 | 2025-10-28 | 0.23 | 0.37 | -37.8% | — | — | -7.9%$40.60→$37.38 |
| Q2 2025 | 2025-07-29 | 0.23 | 0.26 | -11.5% | — | — | — |
| Q1 2025 | 2025-04-29 | 0.11 | 0.28 | -60.7% | — | — | — |
| Q4 2024 | 2025-02-25 | -0.12 | 0.13 | -192.3% | — | — | — |
| Q3 2024 | 2024-10-29 | -0.18 | 0.07 | -357.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.